Ledger.Open graph →
SEC Form D · Amendment · filed February 22, 2024

Adze Biotechnology Inc

Offering
$15.0M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Coral Gables, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Gloria J. Olivier · Rochester, MNDirectorKenneth J. Templin · Oak Park, ILExecGabriel P. Raviv · Glenview, ILDirectorSidney Hopps · Miami, FLExec · DirectorBrendan P. Kenny · Edmonton, Alberta, CanadaDirectorG. P. Sage, Ii · Kalamazoo, MIDirectorDavid Reiss · NEW YORK, NYDirectorStewart Kohl · CLEVELAND, OHDirectorSidney Hopps · Miami, FLExec · DirectorBela Szigethy · NEW YORK, NYDirectorTerrence A. Avella · New York, NYExecJonathan S. Beach · The Woodlands, TXDirectorBernard Lawrence · St Peter Port, Y7ExecSateeta N. Jeewoolall Jessoo · Trianon, O4DirectorSPV Solutions Management I LLC · Salt Lake City, UTDirectorRichard Robb · New York, NYDirectorRoger Renaud · Montreal, Quebec, CanadaDirectorSteve Nawrocki · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗